Results

Total Results: 2,208 records

Showing results for "drug".

341. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/opioids-older-adults/protocol
     August 01, 2020 - metabolism, polypharmacy (resulting in drug-drug interactions), compromised respiration, hypogonadism … Adults: 2015 National Survey on Drug Use and Health. … High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other … Reducing the risk of adverse drug events in older adults. … Am J Drug Alcohol Abuse. 2015;41(6):508-518. 39.

342. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults: Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
     June 29, 2019 - metabolism, polypharmacy (resulting in drug-drug interactions), compromised respiration, hypogonadism … Adults: 2015 National Survey on Drug Use and Health. … High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other … Reducing the risk of adverse drug events in older adults. … Am J Drug Alcohol Abuse. 2015;41(6):508-518. 39.

343. Treatments for Adults with Schizophrenia: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
     September 23, 2016 - Drug Class Review of Atypical Antipsychotic Drugs; Update 3. … Portland, OR: Oregon Health & Science University Drug Effectiveness Review Project; 2010. 17. … Antipsychotic drug use and mortality in older adults with dementia. … Drug Class Review: Second Generation Antipsychotic Drugs. Final Report - Update 4. … Methods for the Drug Effectiveness Review Project. BMC Med Res Methodol. 2012;12(1):140. 34.

344. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
     September 01, 2011 - That raises the question: Why focus on off-label use since expanding FDA approval for an approved drug … We included studies comparing atypicals to other drug classes throughout the report. … Similarly, our summary table of benefits (Table 1) lists each drug seperately for each indication. … Pharmacoepidemiology and drug safety (2011) DOI: 10.1002/pds.2082 The study results indicated 75% … In addition, it shows a trend towards worsening psychosis with this drug.

345. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - The drug/device has been approved in Europe. … Food and Drug Administration (FDA); 2012 Nov 9. 63 p. … Drug list search results: bydureon. [internet]. … FDA approves eye drug for diabetics. [internet]. … Drug formulary. [internet].

346. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - Food and Drug Administration (FDA). … Food and Drug Administration (FDA). … Drug list search results: bydureon. [internet]. … FDA approves eye drug for diabetics. [internet]. … Drug formulary. [internet].

347. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - The a priori determined unit of analysis was drug class. … In some instances, where only a single drug was represented in a class, we provide that drug name so … , not just by drug class vs. … When data for a single drug was available, the drug level comparison is presented (ex. duloxetine … In the “Discussion” chapter under “applicability” we have added “Resulting drug-drug interactions and

348. Management of Primary Headaches in Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/research
     June 01, 2022 - The drugs and drug classes displayed in the visualization above are the only ones for which adequate … In other words, there were no conclusions for drugs and drug classes not listed and no conclusions for … Concomitant drug use (and thus drug-drug interactions) are likely to differ. … for primary headache in breastfeeding women, we recognize that decision makers may be interested in drug … In other words, drug levels are, at best, intermediate outcomes and may not correlate well with harms

349. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
     January 17, 2014 - conclusions on comparative effectiveness of oral diabetes agents were out of date due to a newly approved drug … class (SGLT-2 inhibitors) and new evidence on previously reviewed drug classes.

350. Noninvasive Treatments for Low Back Pain: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/back-pain-treatment/clinician
     June 01, 2021 - versus placebo; ↔ = no difference between the interventions; NSAID = nonsteroidal anti-inflammatory drug … versus placebo; ↔ = no difference between the interventions; NSAID = nonsteroidal anti-inflammatory drug … difference between the interventions; EMG = electromyography; NSAID = nonsteroidal anti-inflammatory drug … Clinicians are advised to refer to individual studies in the report or to the drug labels of each drug … Food and Drug Administration Opioids (immediate-release) Misuse, abuse, addiction, overdose

351. Diabetes-Foot-Ulcer-Amputation-Economics Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
     January 01, 2011 - With respect to drug costs, in thou- sands of U.S. dollars, the mean total cost of all medica- tions … With respect to drug costs, the mean total cost of all medications used by Medicare FFS benefi- ciaries … In this population, all Part D claims in the given year with a National Drug Code (NDC) corresponding … First, the annual total drug cost was defined as the sum of the ingredient cost, dispensing fee, sales … Among Diabetic Medicare Parts A and B FFS Beneficiaries With and Without LEA, 2006-2008 Average Drug

352. Finding Evidence for Comparing Medical Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-finding-evidence/methods
     December 01, 2019 - How useful are unpublished data from the Food and Drug Administration in meta-analysis? … drug name Exp DRUG NAME adverse events, po, to Exp DRUG NAMEadverse events, to floating subheadings … Drug terms AND (ae OR po OR to OR co OR de).fs. … Drug terms AND (ae OR to OR co).fs. … terms AND exp DRUG TOXICITY/ Drug terms AND (exp ADVERSE DRUG REACTION/ OR Exp Side-Effect/ )

353. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
     June 01, 2011 - versus ACEIs or ARBs, and therefore the evidence to discern any differential effects between these drug … ACEI with lower rates of cough, this translates to a difference of 1.2 persistence with drug therapy, … ACEI renin inhibitor trials did not find a statistically significant persistence with drug therapy, and … Persistence with ACEIs and ARBs have similar rates of treatment adherence drug therapy/ based on pill … (2) Relative persistence with drug therapy across the different classes of drugs.

354. Depression SSRI Surveillance Assessment_CER 62_Low-1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
     January 01, 2013 - Food and Drug Administration (FDA), Health Canada, and UK Medicines and Healthcare products Regulatory … would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … from the market, a 3 black box warning) or the availability of a new drug within class (the … Overall, there is limited supportive evidence for any single augmenting drug or for switching to a … or treat*)).tw. 39 ((treat* or therapy or drug) adj4 (resist* or fail*)).tw. 40 27 or 28 or 29

355. medication-assisted-treatment-protocol-160224 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
     February 24, 2016 - associated with additional risks from the high addiction potential of heroin, lack of control over drug … Food and Drug Administrated (FDA) for treatment of this condition accompanied by various psychosocial … Pharmacoepidemiol Drug Saf. Dec 2009;18(12):1166-1175. 7. Volkow ND. … America’s Addiction to Opioids: Heroin and Prescription Drug Abuse. … Prescription Drug Abuse Subcommittee.

356. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Weight loss over 39 weeks depended on drug dose. … Food and Drug Administration). … Food and Drug Administration (FDA). … Food and Drug Administration (FDA); 2012 Nov 9. 63 p. … Food and Drug Administration (FDA).

357. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Food and Drug Administration (FDA) approval was based reported that patients with SBS experienced a … Food and Drug Administration (FDA). FDA approves Gattex to treat short bowel syndrome. … Food and Drug Administration (FDA); 2012 Dec 21 [accessed 2013 Jun 05]. [2 p]. … Specialty drug list. [internet]. … Drug coverage guidelines search: Gattex. [internet].

358. chronic-fatigue-protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
     May 01, 2014 - Food and Drug Administration (FDA) approved medications for the treatment of ME/CFS, but many have … Food and Drug Administration’s (FDS’s) patient-focused drug development initiative, treatments fell … Center for Drug Evaluation and Research. … Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. … Food and Drug Administration; 2013.

359. Management of Primary Headache During Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/protocol
     May 01, 2020 - Other drug within class. … Same drug(s), different route, treatment duration, initiation time, or other aspect. … Other drug within class. … Same drug(s), different route, treatment duration, initiation time, or other aspect. … Curr Drug Metab. 2012 May 1;13(4):474-90. PMID: 22299823. 15. U.S. Food and Drug Administration.

360. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) to treat patients with PsA are adalimumab, etanercept, golimumab, … The first review did not include certolizumab pegol, golimumab, and tocilizumab drug therapies listed … KQ3: For patients with psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence … Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults